Cell line · CVCL_0543
SW1353
Cancer cell line, Homo sapiens. Primary central chondrosarcoma. 34 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SW1353. Cell lines, record CVCL_0543. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0543
On this page
Cell line
As Cellosaurus gives it.
- Name
- SW1353
- Accession
- CVCL_0543
- RRID
- RRID:CVCL_0543
- Synonyms
- SW-1353, SW 1353
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 72Y
- Category
- Cancer cell line
- Diseases
- Primary central chondrosarcoma (NCIt C7155); Chondrosarcoma (ORDO Orphanet_55880)
- Derived from
- Bone, right humerus (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers34
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro. | J Bone Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MITF maintains genome stability in nonmelanocyte lineages. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mitochondrial dysfunction activates ADAMTS-5 expression via mt-dsRNA-PKR-Spi-1 axis in osteoarthritic chondrocytes. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Drug Screening of Sarcoma Cells: Finding Shared Sensitivities. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LARS promotes osteosarcoma proliferation through leucine-dependent PRIM2 translation and DNA replication activation. | J Exp Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights. | Mol Ther Nucleic Acids | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression. | J Transl Med | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Genetic transcriptional regulation profiling of cartilage reveals pathogenesis of osteoarthritis. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Protein Phosphatase 1 Regulatory Subunit 3C integrates cholesterol metabolism and isocitrate dehydrogenase in chondrocytes and neoplasia. | Proc Natl Acad Sci U S A | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 34
See all 34 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte SW1353 stable cell line for hHMGA2 overexpression | CVCL_F4M8 | Cell lines | |
| Derived from it | HyCyte SW1353-Luc | CVCL_E3IP | Cell lines |
Cell banks9
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-94 | ATCC | |
| BCRC | 60548 | BCRC | |
| BCRJ | 0382 | BCRJ | |
| CLS | 300440 | CLS | |
| Hysigen | TCH-C342 | Hysigen | |
| ICLC | HTL99008 | ICLC | |
| IZSLER | BS TCL 213 | Cellosaurus | |
| NCBI_Iran | C571 | Cellosaurus | |
| Ubigene | YC-C105 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0543
GET https://conductscience.org/api/cell-lines/v1/CVCL_0543/papers?page=2